Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can already provide sufficient statistical power to support ...
On-body injector delivery of subcutaneous teprotumumab achieves clinically meaningful proptosis reduction in phase 3 thyroid eye disease study.
BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...
Smithsonian Magazine on MSN
What lies beyond Artemis 2? These other missions are setting their sights on the Moon this year—and on a future with humans in space
After rounding the moon, viewing a solar eclipse and traveling farther than any human had before, the four astronauts of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results